Cytokinetics reported that its drug aficamten significantly improved symptoms in patients with non-obstructive hypertrophic cardiomyopathy, advancing prospects for FDA approval. In parallel, Wolfson ...
GLP-1 receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide agonists are not likely to decrease the ...
A lower-court ruling had reinstated a Food and Drug Administration requirement that patients visit a health care provider in ...
Scientists have identified novel genetic interactions that may contribute to congenital heart disease (CHD), a common birth defect. Scientists at the Icahn School of Medicine at Mount Sinai and ...
A new study from the University of St Andrews suggests weight-loss drugs like Ozempic taken around pregnancy do not raise the ...
Legislators and health experts are seeking to combat a common birth defect with one simple ingredient added to staple foods.
A landmark study led by researchers at the University of Nebraska Medical Center (UNMC) and published in Molecular Psychiatry has identified a significant association between prenatal prescription of ...
Women in the U.S. gave birth to roughly 710,000 fewer children last year compared with the nation's peak in 2007, according to preliminary data released this week by the Centers for Disease Control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results